Oklahoma could soon be latest state to have breast density reporting bill in place

A new bill being considered by the Oklahoma state legislature could make the Sooner state the latest to have a breast density reporting bill signed into law.

If passed, the law would require mammography reports to inform patients with dense breast tissue that they may be at a higher risk of breast cancer and are encouraged to discuss the matter with their healthcare provider.

According to Are You Dense Advocacy, Inc., 24 states have already enacted similar legislation.

HB 2601’s story begins in 2014, when Joe Jennings lost his wife, Kristen, to breast cancer at a young age.

“She couldn't get a mammogram because she was too young,” Jennings said, as quoted by KTUL in Tulsa. “She was age 32 when she was diagnosed and six months prior to that is when she found the lump, went to the doctor and was told no.”

Jennings and his two daughters have been working toward getting HB 2601 passed in the state senate ever since.

“If it doesn't pass out of the committee it's dead,” Jennings said, as quoted by KTUL. “But this bill is important because most women out there have dense breasts, most women their tumors won't be found. They need that further testing.”

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.